[go: up one dir, main page]

PE20071090A1 - 5-pirazolpiperidinas-(sustituidas) - Google Patents

5-pirazolpiperidinas-(sustituidas)

Info

Publication number
PE20071090A1
PE20071090A1 PE2006001542A PE2006001542A PE20071090A1 PE 20071090 A1 PE20071090 A1 PE 20071090A1 PE 2006001542 A PE2006001542 A PE 2006001542A PE 2006001542 A PE2006001542 A PE 2006001542A PE 20071090 A1 PE20071090 A1 PE 20071090A1
Authority
PE
Peru
Prior art keywords
chlorophenylsulfonil
tetrahydro
pyridine
alkyl
substituted
Prior art date
Application number
PE2006001542A
Other languages
English (en)
Inventor
Jacek Jagodzinski
Ying-Zi Xu
Xiaocong Michael Ye
Andrei Konradi
Jenifer Smith
Albert Garofalo
Christopher Semko
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of PE20071090A1 publication Critical patent/PE20071090A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A DERIVADOS DE 5-PIRAZOLPIPERIDINAS-(SUSTITUIDAS) DE FORMULA (I), EN DONDE A ES ARILO, CICLOALQUILO, HETEROARILO O HETEROCICLOALQUILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS; B ES HETEROARILO O HETEROCICLOALQUILO, TAL COMO PIRAZOLILO, IMIDAZOLILO, ENRE OTROS, OPCIONALMENTE SUSTITUIDOS; R1, R1a, R2 Y R2a SON INDEPENDIENTEMENTE H, HALOGENO, ALQUILO(C1-C6), ALQUENILO(C2-C6), ARILO, HETEROARILO, -CO2R', CONR'R'', ENTRE OTROS; R3, R3a SON INDEPENDIENTEMENTE H, HALOGENO O ALQUILO(C1-C6). SON SELECCIONADOS: 5-(4-CLOROFENILSULFONIL)-6-FENIL-4,5,6,7-TETRAHIDRO-2H-PIRAZOLO[4,3-c]PIRIDINA, 5-(4-CLOROFENILSULFONIL)-6-(3-FLUOROFENIL)-4,5,6,7-TETRAHIDRO-1H-PIRAZOLO[4,3-c]PIRIDINA, 6-BENCIL-5-(4-CLOROFENILSULFONIL)-4,5,6,7-TETRAHIDRO-1H-PIRAZOLO[4,3-c]PIRIDINA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS INHIBEN LA LIBERACION DE LA GAMMA SECRETASA Y PEPTIDO ß-AMILOIDEO POR LO QUE SON UTILES EN EL TRATAMIENTO DE DESORDENES COGNOSCITIVOS TAL COMO LA ENFERMEDAD DE ALZHEIMER
PE2006001542A 2005-12-01 2006-12-01 5-pirazolpiperidinas-(sustituidas) PE20071090A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74136605P 2005-12-01 2005-12-01

Publications (1)

Publication Number Publication Date
PE20071090A1 true PE20071090A1 (es) 2007-10-24

Family

ID=38092841

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001542A PE20071090A1 (es) 2005-12-01 2006-12-01 5-pirazolpiperidinas-(sustituidas)

Country Status (18)

Country Link
US (2) US7732609B2 (es)
EP (1) EP1957458A2 (es)
JP (1) JP2009518301A (es)
KR (1) KR20080073359A (es)
CN (1) CN101370776A (es)
AR (1) AR057959A1 (es)
AU (1) AU2006320423B2 (es)
BR (1) BRPI0619633A2 (es)
CA (1) CA2632227A1 (es)
EA (1) EA014906B1 (es)
EC (1) ECSP088593A (es)
IL (1) IL190608A0 (es)
MA (1) MA30089B1 (es)
MY (1) MY149422A (es)
NZ (1) NZ568109A (es)
PE (1) PE20071090A1 (es)
TW (1) TW200736255A (es)
WO (1) WO2007064914A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008015057A (es) * 2006-05-31 2008-12-10 Galapagos Nv Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias.
WO2008147800A1 (en) * 2007-05-25 2008-12-04 Elan Pharmaceuticals, Inc. Pyrazolopyrrolidines as inhibitors of gamma secretase
CN102083797B (zh) 2008-04-01 2014-06-04 Abbvie公司 四氢异喹啉、含有它们的药物组合物和它们在治疗中的用途
TW201038569A (en) * 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
CN102439010A (zh) * 2009-03-25 2012-05-02 艾伦药物公司 稠合三环磺酰胺的制备方法
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2014001457A (es) 2011-08-05 2014-08-21 Abbvie Deutschland Derivados de aminocromano, de aminotiocromano y de amino-1,2,3,4-tetrahidroquinolina composiciones farmaceuticas que los contienen, y su uso en terapia.
CN104011028A (zh) 2011-11-18 2014-08-27 艾伯维德国有限责任两合公司 N-取代的氨基苯并环庚烯、氨基四氢化萘、氨基茚满和苯烷基胺衍生物、包含所述衍生物的药物组合物及其在治疗中的用途
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
AU2014336154A1 (en) 2013-10-17 2016-04-28 AbbVie Deutschland GmbH & Co. KG Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
AU2014336153A1 (en) 2013-10-17 2016-04-28 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CN104059063A (zh) * 2014-04-03 2014-09-24 丽水绿氟科技有限公司 7,7-二氟-4,5,6,7-四氢吡唑并[4,3-c]吡啶及其衍生物的制备方法
SMT202200134T1 (it) 2018-03-08 2022-05-12 Incyte Corp Composti di amminopirazindiolo come inibitori di pi3k-y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL319758A1 (en) * 1994-10-20 1997-08-18 Pfizer Bicyclic tetrahydropyrasole pyridines and their application as medicines
BR0113176A (pt) * 2000-08-10 2003-06-17 Pharmacia Italia Spa Compostos biciclo-pirazol, composições farmacêuticas compreendendo os compostos, uso dos compostos na fabricação de medicamentos, processos para a preparação dos compostos, coleção quìmica combinatória e métodos para o tratamento de mamìferos incluindo humanos utilizando os compostos
CA2468529C (en) * 2001-10-09 2011-03-01 Kyorin Pharmaceutical Co., Ltd. 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
WO2004060892A1 (ja) * 2002-12-27 2004-07-22 Japan Tobacco Inc. 縮合ｎ含有ヘテロ環化合物及びその医薬用途
EP1758884A2 (en) * 2004-05-20 2007-03-07 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
KR20070074638A (ko) 2004-10-27 2007-07-12 얀센 파마슈티카 엔.브이. 테트라하이드로 피리디닐 피라졸 카나비노이드 모듈레이터
DE102005002500A1 (de) * 2005-01-19 2006-07-27 Sanofi-Aventis Deutschland Gmbh Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
CN101175754A (zh) * 2005-03-22 2008-05-07 阿斯利康(瑞典)有限公司 用作CB1受体配体的新四氢-1H-吡啶并[4,3-b]吲哚衍生物
DE102005016170A1 (de) * 2005-04-07 2006-10-12 Grünenthal GmbH 4,5,6,7- Tetrahydro-isoxazolo(4,5c)pyridin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
EP1916985A4 (en) * 2005-08-19 2010-06-09 Elan Pharm Inc BRIDGED N-CYCLIC SULPHONAMIDE INHIBITORS OF THE GAMMED CRYSTETRY

Also Published As

Publication number Publication date
BRPI0619633A2 (pt) 2011-10-04
WO2007064914A2 (en) 2007-06-07
IL190608A0 (en) 2008-11-03
AU2006320423B2 (en) 2012-06-21
AR057959A1 (es) 2007-12-26
ECSP088593A (es) 2008-08-29
US20100267747A1 (en) 2010-10-21
AU2006320423A1 (en) 2007-06-07
EA014906B1 (ru) 2011-02-28
MA30089B1 (fr) 2008-12-01
KR20080073359A (ko) 2008-08-08
EP1957458A2 (en) 2008-08-20
NZ568109A (en) 2011-07-29
CA2632227A1 (en) 2007-06-07
US20070155753A1 (en) 2007-07-05
WO2007064914A8 (en) 2008-05-15
US7732609B2 (en) 2010-06-08
EA200801481A1 (ru) 2009-02-27
TW200736255A (en) 2007-10-01
CN101370776A (zh) 2009-02-18
MY149422A (en) 2013-08-30
WO2007064914A3 (en) 2007-12-27
JP2009518301A (ja) 2009-05-07

Similar Documents

Publication Publication Date Title
PE20071090A1 (es) 5-pirazolpiperidinas-(sustituidas)
PE20060479A1 (es) Compuestos heteroaril-aril-ureas como inhibidores de la quinasa
PE20060599A1 (es) DERIVADOS PIRAZOLO-[3,4-d]-PIRIMIDINA COMO INHIBIDORES DE LA ACTIVIDAD DEL RECEPTOR CANNABINOIDE 1
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
SE0402735D0 (sv) Novel compounds
PE20061106A1 (es) Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida
PE20091211A1 (es) Derivados de pirazolopirimidina como moduladores de pde9a
PE20060531A1 (es) Derivados de piridazin-3-(2h)-ona como inhibidores de la fosfodiesterasa 4
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
PE20050664A1 (es) Derivados de 1h-imidazo[4,5-c]quinolina
UY29458A1 (es) Heterociclos sustituidos y usos de los mismos
PE20070790A1 (es) Derivados de 2-aminopirimidina como moduladores de la actividad del receptor de histamina h-4
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
AR059957A1 (es) DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER.
HUP0300059A2 (hu) Kinazolinszármazékok, eljárás az előállításukra, és a vegyületeket tartalmazó gyógyszerkészítmények, valamint az új és ismert kinazolinszármazékok alkalmazása proliferatív betegségek ellen
UY28564A1 (es) Compuestos quimicos
IL189191A0 (en) Thiazolyl piperidine derivatives useful as h3 receptor modulators
NO20053748L (no) Pyrrolopyridazinderivater.
NO20085323L (no) Smeltede, tricykliske sulfonamidinhibitorer av gammasekretase
PE20060625A1 (es) Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina
PE20081492A1 (es) Derivados de sulfonamida heterociclicos como antagonista de edg-1
PE20090280A1 (es) Pirazol-pirrolidinas como inhibidores de gamma secretasa
NO20082214L (no) 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
DK1448562T3 (da) Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer
MX2008002234A (es) Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.

Legal Events

Date Code Title Description
FC Refusal